Delivery Order SPE2DB20D9759-SPE2DB24FD5LK
- Not listed
- This federal contract award, valued at $4,227.15, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of Alfuzosin HCL ER 10 mg tablets to fulfill the recurring medical supply needs of military health facilities. The award is a firm fixed-price delivery order under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $1,948.20 to DMS Pharmaceutical Group Inc. for Alfuzosin Hydrochloride, a pharmaceutical product used in the treatment of benign prostatic hyperplasia. The contract, issued on May 13, 2025, with an ultimate completion date of May 23, 2025, was awarded without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,449.52, is for the delivery of Alfuzosin Hydrochloride Extended-Release 10 mg tablets. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,844.60 contract is for the delivery of Alfuzosin Hydrochloride, a pharmaceutical product, with a completion date of March 21, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Alfuzosin Hydrochlo medical supplies, with a ceiling value of $5,844.60 and an ultimate completion date of July 18, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,673.32 under an indefinite delivery contract with the Defense Logistics Agency to supply alfuzosin hydrochloride. The delivery order was awarded on August 30, 2022 with a completion date of September 9, 2022. DMS Pharmaceutical Group will provide the pharmaceutical item to Defense Logistics Agency Troop Support Medical facilities located in Park Ridge, Illinois. DMS Pharmaceutical Group is a woman-owned small...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $3,848.60 issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract provides for the delivery of 4,565,252,933 tablets of the generic drug Tamsulosin Hydrochloride 0.4 mg to the DLA by July 23, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,924.40 firm fixed-price delivery order is for a wide range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract supports the recurring medical supply needs of military...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,221.12, is a firm fixed-price delivery order for the supply of a specialized medication, Altafluor Benox 0.25%-0.4% DRP 5ML, with a period of performance ending on December 7, 2021. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at up to $4,542.72, is a firm-fixed price delivery order for the supply of various pharmaceutical products, including medications such as FOSAMAX 70 MG TABLET. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
- SPE2DB20D9759Indefinite Delivery Contract
- SPE2DB20D9759-SPE2DB24FD5LKDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,062.77 firm fixed-price delivery order is for the supply of Alfuzosin HCl ER 10 mg tablets, with a completion date of May 9, 2024. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The current award is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal contracts across multiple product categories and medical domains. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated its capability to provide a diverse array of pharmaceutical products to the DLA through previous contract awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/8/24 |